Development and clinical application research of new preventive treatment method by neuropeptide PACAP for brain and spinal cord injury.
Description: Though the preparation of the KO-mouse of PAC1 receptor which is directly concerned in the delayed neuronal death was possible, there are many individuals who die immediately after the birth, and it is necessary to increase the number of individuals.It was proven that the intrinsic PACAP suppressed the delayed neuronal death of the hippocampus in the animal experiment using PACAP KO mouse, and it was also concerned in nerve regeneration and newborn. In addition, it was also clarified that PACAP manifested CRMP2 which is the axon extension factor in the culture experiment, and that it promotes the axon extension through NrdA1 which is the transcription factor. However, primate marmosets are not suitable for purpose because animals cannot increase a small number of animals. Morever, the superagonist of PAC1R is being searched at present.
Amount: ¥46,150,000
Funding type: research
Funder scheme: Grant-in-Aid for Scientific Research (A)
Start date: 2016-04-01
End date: 2021-03-31
Investigator: Seiji Shioda (lead)
Institution: Hoshi University
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Funded outputs count: 27
Funder award ID: 16H02684
OpenAlex ID: G3744996058
